New Targets in Developing Dementia Treatments

Beyond Amyloid and Tau

Health & Lifestyle
210

Listen to article (english)

Translate to Spanish or other 102 languages!

Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Image for illustration purposes
Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Image for illustration purposes

Medical News Today

- Advertisement -

Alzheimer’s disease is the most common form of dementia. Although its exact cause is unknown, for many years scientists have believed that a protein called beta-amyloid was responsible. Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Here, we round up the latest findings, look at possible advances in diagnosis, and ask: Where next for Alzheimer’s research and treatment?

To read the full story, follow the link below to Medical News Today:

https://www.medicalnewstoday.com/articles/beyond-amyloid-and-tau-new-targets-in-developing-dementia-treatments

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
The Importance of Sun Safety
Next article
2023 Hurricane Season: June 1st – November 30th

More Articles

Despite a Cure, Millions Remain Untreated for Hepatitis C

Mega Doctor News by University of Virginia Newswise — CHARLOTTESVILLE, Va. – Millions of Americans...

Updated Guidance Seeks to Reduce Risks From Pulmonary Embolism

Mega Doctor News American Heart Association Clark was 32 in the fall of...

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.
- Advertisement -